Skip to main content

Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension

Completed · Phase 3 · NCT03850782

Conditions: Open-Angle Glaucoma, Ocular Hypertension

At a glance

Research payments reported, 2025
$822,096
U.S. investigators named
26
Sites paid
40
Planned or actual enrollment
515

About the trial

Sponsor
AbbVie
Tested
Bimatoprost (SR) (drug)
Dates
Started 2019-02-28; completion 2025-08-08
Results posted
Not yet

This study evaluates the duration of intraocular pressure (IOP)-lowering effect and safety of as needed administrations of Bimatoprost sustained release (SR) in participants with open-angle glaucoma (OAG) or ocular hypertension (OHT) who are not adequately managed with topical IOP-lowering medication for reasons other than medication efficacy.

From ClinicalTrials.gov, last updated 2025-08-19. Full record, eligibility and contacts (opens in a new tab)

Industry funding

AbbVie Inc. reported $822,096 in research payments for this study in 2025 (112 payments).

Products named: Durysta

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

  • Piedmont Eye Center Inc $75,664
  • Doc Trials LLC $56,461
  • Vanderbilt University Medical Center, TN $41,501
  • Michigan Eye Care Provider PLLC $38,225
  • Moyes Eye Center PC $37,445
  • Migs Consulting LLC $35,389
  • Advancing Vision Research LLC $35,047
  • Scott & Christie and Associates $33,313
  • Thomas Eye Group PC $31,257
  • The Administrators of the Tulane $30,543
  • University of Michigan Health System, MI $28,736
  • Fort Wayne Retina PC $27,280
  • Lakeside Vision Center $23,424
  • Doctrials $22,227
  • Indiana University Health Center $21,899
  • Piedmont Eye Center $20,375
  • Advanced Research LLC $19,909
  • Medical Center Ophthalmology Associates $19,215
  • Scott and Christie Eyecare Associates PC $19,165
  • Keystone Operations LLC $18,522
  • Danbury Eye Physicians and Surgeons $18,522
  • Ophthalmic PArtners PC $15,924
  • Danbury Eye Physicians & Surgeons $15,522
  • Vance Thompson Vision Clinic $13,579
  • Eye Specialty Group $11,787
  • Vance Thompson Vision $11,025
  • Black Hills Regional Eye Institute $11,025
  • Ophthalmic Consultants of Boston $11,025
  • Fraser Eye Care Center $11,025
  • Ophthalmic PArtners of Pennsylvania $10,715
  • Tulane University School of Medicine Office of Academic Affairs $10,022
  • Fine Hoffman and Sims LLC $10,022
  • Eye Research Foundation $10,022
  • Texan Eye PA $6,951
  • Vrf Eye Specialty Group $5,839
  • Efraim Duzman MD Inc $3,844
  • Drs Fine Hoffman & Sims LLC $3,280
  • Eye Research Foundation Inc $3,280
  • Indiana University $2,028
  • Segal Drug Trials $1,062

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.